Key Takeaways
- Digital health investors are seeing a resurgence with Hinge Health’s successful IPO and Omada Health’s upcoming IPO.
- Healthcare AI assistant startups are thriving, with significant funding and valuation increases.
- Emerging venture capital managers are struggling, with a notable drop in first-time fund launches in 2025.
Digital health investors are experiencing a mix of challenges and optimism as they navigate the market landscape. Hinge Health’s recent IPO has provided some liquidity, even though it valued the company at less than half of its $6.2 billion valuation during its last funding round in 2022. Despite this, early investors like Insight Partners and Atomico saw considerable gains as Hinge’s shares jumped from an offering price of $32 to over $39 within a week. Meanwhile, Omada Health, a virtual chronic care startup, is preparing for its IPO with a pricing range set between $18 and $20 per share.
The healthcare AI sector remains vibrant, with startups like OpenEvidence achieving a $3 billion valuation and Abridge seeking funding at a $5 billion valuation. Investors indicate that many AI startups initially focused on automating back-office operations in healthcare, such as billing and insurance verification. Two promising companies, Brellium and Thatch, are recognized for their compliance and benefits automation solutions.
Private medical practices have been early adopters of AI tools, with startups developing large language models (LLMs) to assist in diagnosis and treatment. Firms such as OpenEvidence are tailoring AI systems using data from medical journals to improve patient care safety. Hippocratic AI, an “AI nurse,” recently secured $141 million in Series B funding for its chronic care management platform and claims to have achieved safety levels comparable to human nurses in certain situations. On the other hand, Limbic offers an AI chatbot for mental health diagnosis and has launched a voice AI tool in the U.S.
Investments in health tech AI surged to $13.8 billion in 2024 after a lull, with predictions that 2025 will see even greater investment if current trends continue. However, the number of deals has declined, as capital concentrates on late-stage successes.
In the venture capital space, the divide remains stark: established megafunds continue to secure capital, while mid-tier and emerging fund managers face significant challenges. Data from PitchBook reveals that only 44 VC funds were launched by first-time fund managers in the first quarter of 2025, a staggering drop from 994 in 2022. Family offices and affluent individuals are reportedly pulling back on investments, exacerbated by recent political and economic shifts affecting funding sources.
Investor highlights include Jim Breyer, who invested early in Facebook and has secured a substantial stake in the emerging stablecoin company Circle, which recently filed to go public with a valuation around $6 billion. Breyer’s early involvement in Circle has resulted in a share worth approximately $400 million. In contrast, Kleiner Perkins’ Leigh Marie Braswell is recognized for leading significant investments in tech startups, including Neon, which was recently acquired by Databricks for $1 billion.
The content above is a summary. For more details, see the source article.
